Discover
SGMT
Sagimet Biosciences Inc.
9.52
1 x 8.85
1 x 9.98
bid
ask
-
0.05
0.52%
1 @ 04:00 PM
8.85 -0.67 (7.03%)
| Ytd | 60.81% | |
| 1y | 8.80% |
9.28
day range
10.01
4.50
52 week range
10.06
| Open | 9.57 | Prev Close | 9.57 | Low | 9.28 | High | 10.01 | Mkt Cap | 310.18M |
| Vol | 0.00 | Avg Vol | 1.12M | EPS | -1.34 | P/E | -7.10 | Forward P/E | -1.40 |
| Beta | 3.37 | Short Ratio | 1.37 | Inst. Own | 66.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 7.29 | 200-d Avg | 6.61 | 1yr Est | 29.14 |
| Income Statement | |||
| Operating Expenses | 11.71M | ||
| Research and Development Expense | 7.00M | ||
| Selling, General and Administrative Expense | 4.72M | ||
| Operating Income | -11.71M | ||
| Net Income | -10.65M | ||
| Net Income Common Stock | -10.65M | ||
| Net Income Common Stock (USD) | -10.65M | ||
| Consolidated Income | -10.65M | ||
| Earnings per Basic Share | -0.33 | ||
| Earnings per Basic Share (USD) | -0.33 | ||
| Earnings per Diluted Share | -0.33 | ||
| Earning Before Interest & Taxes (EBIT) | -10.65M | ||
| Earning Before Interest & Taxes (USD) | -10.65M | ||
| Weighted Average Shares | 32.56M | ||
| Weighted Average Shares Diluted | 32.56M | ||
| Balance Sheet | |||
| Cash and Equivalents | 36.63M | ||
| Cash and Equivalents (USD) | 36.63M | ||
| Investments | 67.91M | ||
| Investments Current | 67.91M | ||
| Current Assets | 107.72M | ||
| Property, Plant & Equipment Net | 39.00K | ||
| Total Assets | 107.76M | ||
| Debt Current | 39.00K | ||
| Total Debt | 39.00K | ||
| Current Liabilities | 5.30M | ||
| Total Liabilities | 5.30M | ||
| Accumulated Retained Earnings (Deficit) | -357.00M | ||
| Accumulated Other Comprehensive Income | 8.00K | ||
| Shareholders Equity | 102.46M | ||
| Shareholders Equity (USD) | 102.46M | ||
| Assets Non-Current | 39.00K | ||
| Total Debt (USD) | 39.00K | ||
| Trade and Non-Trade Payables | 2.30M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 39.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.61M | ||
| Net Cash Flow from Investing | 10.22M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 10.22M | ||
| Net Cash Flow from Operations | -8.61M | ||
| Share Based Compensation | 1.84M | ||